Immunotherapy | CHOP Research Institute
 

Immunotherapy

Published on
Sep 3, 2025
Researchers identified a potential therapeutic vulnerability in pediatric high-grade gliomas.
Published on
May 13, 2025
Scientists, staff, and students from CHOP and the University of Pennsylvania community celebrated the next generation of pediatric researchers and the continuation of collaborative scientific discovery at the Poster Day and Scientific Symposium.
Published on
Apr 9, 2025
Jessica Foster, MD, this month’s Faculty Spotlight, is working hard to bring immunotherapy treatments for brain and spinal cord tumors from bench to bedside.
Published on
Jan 6, 2025
The CHOP-led trial showed that blinatumomab plus chemotherapy drastically improved survival rates for patients with B-ALL.
Published on
Dec 30, 2024
We tallied up the most popular Cornerstone blog stories of 2024 based on data across our CHOP Research social media platforms.
Published on
Dec 20, 2024
Congratulations to two CHOP physicians and researchers who were inducted as new fellows into the College of Physicians of Philadelphia.
Published on
Dec 19, 2024
As the pediatric cancer charity celebrates its 20th anniversary, Cornerstone is highlighting the groundbreaking research at CHOP fueled by two decades of collaboration.

Dr. Wang directs the Cell Based Therapy Lab (CBTL) at CHOP. The CBTL is a cGMP facility manufacturing cell and gene therapy products for use in bone marrow transplant, adoptive immune therapy, and many other cutting edge applications in medicine.

E-mail:
wangy2 [at] chop.edu

The Li Lab develops cutting-edge computational programs for analyzing large cancer genomics data, with a focus on understanding tumor-immune interactions.

Published on
Oct 30, 2024
Adam Wolpaw, MD, PhD, and Timothy Spear, MD, PhD, have been awarded grants from Hyundai Hope On Wheels to improve CAR T-cell therapy.